Latest Artificial pancreas Stories
The world's first clinical trial comparing three alternative treatments for type 1 diabetes was conducted in Montréal by researchers at the IRCM and the University of Montreal, led by endocrinologist Dr. Rémi Rabasa-Lhoret.
PHILADELPHIA, Nov. 3, 2014 /PRNewswire/ -- Echo Therapeutics, Inc.
First Ever Person with Type 1 Diabetes Receives Experimental Encapsulated Human Stem Cell-Derived Beta Cell Replacement Therapy NEW YORK, Oct.
Demonstrates Proof-of-Concept for ORMD-0801 Oral Insulin to Reduce Exogenous Insulin Requirements JERUSALEM, October 22, 2014 /PRNewswire/ -- Oramed Pharmaceuticals
Uppsala University Hospital in Sweden will enroll 8 patients in the study, partially supported by a recent grant by the JDRF ROSH HAAYIN, Israel, October 21, 2014 /PRNewswire/ --
BRIDGEWATER, N.J., Oct.
-- Digital health and information company looks to aid artificial pancreas systems for diabetes treatment -- BOULDER, Colo.
The company's distinctive dual strategy, devised to help it penetrate developing and developed regions, has fuelled its success LONDON, Sept.
--New Collaboration will Increase Data Available to Artificial Pancreas Researchers -- NEW YORK and SAN FRANCISCO, Sept.
ROSH HA-AYIN, Israel, September 10, 2014 /PRNewswire/ -- Beta-O2 announced today that it has received a $500K grant from JDRF.
- To give a box on the ear to.
More Images (1 images) »